Literature DB >> 14648479

[Genetics of autism: from genome scans to candidate genes].

Stéphane Jamain1, Catalina Betancur, Bruno Giros, Marion Leboyer, Thomas Bourgeron.   

Abstract

The autistic disorder was firstly described by Leo Kanner sixty years ago. This complex developmental disability is characterized by social and communicative impairments and repetitive and stereotyped behaviours and interests. The prevalence of autism in the general population is about 1 in 1,000, with four males affected for one female. In approximately 15% of the cases, autism is associated with known genetic disorders, such as fragile X syndrome, tuberous sclerosis or Rett syndrome. Nevertheless, a recognised medical etiology can only be identified in a minority of cases. A higher recurrence risk in families with autistic subjects (45 times greater than the prevalence in the general population) and higher concordance for autism among monozygotic (60-90%) than dizygotic (0-10%) twins argue for a genetic predisposition to idiopathic autism. The past decade has been marked by an increased interest in the genetic basis of autism, with a series of multiple independent whole genome scans and chromosomal abnormalities studies. These analyses have pointed out several candidate regions on chromosomes 2q, 7q, 6q, 15q and sex chromosomes. These regions possess candidate genes that have been screened for mutations or association with autism. However, a clear involvement of a major susceptibility gene (or genes) in autism remains far from clear. The results from linkage studies and the clear drop in the concordance rates between monozygotic and dizygotic twins suggests that the genetic aetiology of autism is certainly heterogeneous (different genes in different families) and polygenic (more than one affected gene per individual). The almost finished sequence of the human genome and the generation of haplotype maps will shed light on the inter-individual genetic variability and will certainly increase the power and reliability of association studies for complex traits, such as autism.

Entities:  

Mesh:

Year:  2003        PMID: 14648479     DOI: 10.1051/medsci/200319111081

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  6 in total

Review 1.  Communication, interventions, and scientific advances in autism: a commentary.

Authors:  Danielle C Llaneza; Susan V DeLuke; Myra Batista; Jacqueline N Crawley; Kristin V Christodulu; Cheryl A Frye
Journal:  Physiol Behav       Date:  2010-01-21

Review 2.  Current developments in the genetics of autism: from phenome to genome.

Authors:  Molly Losh; Patrick F Sullivan; Dimitri Trembath; Joseph Piven
Journal:  J Neuropathol Exp Neurol       Date:  2008-09       Impact factor: 3.685

Review 3.  Deep molecular diversity of mammalian synapses: why it matters and how to measure it.

Authors:  Nancy A O'Rourke; Nicholas C Weiler; Kristina D Micheva; Stephen J Smith
Journal:  Nat Rev Neurosci       Date:  2012-05-10       Impact factor: 34.870

4.  Autism and metabolic cytopathy.

Authors:  Mehmet Emin Ceylan; Ayse Fulya Maner; Ahmet Turkcan; Agah Aydin
Journal:  Open Neuroimag J       Date:  2011-08-05

5.  Cytogenetic abnormalities and fragile-X syndrome in Autism Spectrum Disorder.

Authors:  Kavita S Reddy
Journal:  BMC Med Genet       Date:  2005-01-18       Impact factor: 2.103

6.  Paving Plant-Food-Derived Bioactives as Effective Therapeutic Agents in Autism Spectrum Disorder.

Authors:  Natália Cruz-Martins; Cristina Quispe; Celale Kırkın; Ezgi Şenol; Aslı Zuluğ; Beraat Özçelik; Adedayo O Ademiluyi; Olubukola Helen Oyeniran; Prabhakar Semwal; Manoj Kumar; Farukh Sharopov; Victor López; Francisco Les; Iulia-Cristina Bagiu; Monica Butnariu; Javad Sharifi-Rad; Mohammed M Alshehri; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2021-08-21       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.